Ledger.Open graph →
SEC Form D · filed June 24, 2024

Marea Therapeutics, Inc

Offering
$160.4M
Sold
$65.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Ted Love · San Francisco, CADirectorMark Joing · San Francisco, CAExecJeff Tong · San Francisco, CADirectorChristine Garrett · San Francisco, CAExecJosh Lehrer · SOUTH SAN FRANCISCO, CAExec · DirectorEthan Weiss · San Francisco, CAExecAaron Royston · South San Francisco, CADirectorCaitlin Murray · San Francisco, CAExecJung Choi · San Francisco, CADirectorMaha Katabi · South San Francisco, CADirectorAntoine Boulanger · San Francisco, CADirectorChris Garabedian · Delanson, NYDirectorMark Joing · San Francisco, CAExecJeff Tong · San Francisco, CADirectorChristine Garrett · San Francisco, CAExecJosh Lehrer · SOUTH SAN FRANCISCO, CAExec · DirectorEthan Weiss · San Francisco, CAExecAaron Royston · South San Francisco, CADirectorCaitlin Murray · San Francisco, CAExecJung Choi · San Francisco, CADirectorMaha Katabi · South San Francisco, CADirectorTed Love · South San Francisco, CADirectorAntoine Boulanger · San Francisco, CADirectorChris Garabedian · Delanson, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗